Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck(Mayo Clinic in Arizona), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Thomas M. Atkinson(Memorial Sloan Kettering Cancer Center), Robert D. Siegel(OSF Saint Francis Medical Center), Andrea Denicoff(National Cancer Institute), Charles S. Cleeland(The University of Texas MD Anderson Cancer Center), Jay K. Harness(St. Joseph Hospital), Tito R. Mendoza(The University of Texas MD Anderson Cancer Center), Lori M. Minasian(National Cancer Institute), Kathleen M. Castro(National Cancer Institute), Antonia V. Bennett(Memorial Sloan Kettering Cancer Center), Bryce B. Reeve(Duke University Health System), Theresa A. Gillis(Christiana Care Health System), Lauren J. Rogak(Memorial Sloan Kettering Cancer Center), Donna Bryant(Child Development Center), Jeff A. Sloan(Mayo Clinic in Florida), Amy P. Abernethy(Parkland Health & Hospital System), Deborah Schrag(Dana-Farber Brigham Cancer Center), Diane Β. Paul(American Speech Language Hearing Association), Yuelin Li(Memorial Sloan Kettering Cancer Center), Ann M. O’Mara(National Cancer Institute), Steven B. Clauser(University of North Carolina at Chapel Hill), Deborah Watkins Bruner(Emory University), James D. Bearden(Spartanburg Regional Healthcare System), Sandra A. Mitchell(National Institutes of Health)
JAMA Oncology
August 13, 2015
Cited by 1,013


Related Papers